Tagged: drug delivery

Prien and MacWilliam bequests establish new endowed professorships

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

MacDougall study finds severe sepsis alert speeds drug delivery

Sepsis occurs when the body responds to an infection with a mix of tissue-damaging inflammation and anti-inflammatory responses. This biological storm can lead to acute organ dysfunction (severe sepsis) and dropping blood pressure that does not respond to intravenous fluids (septic shock).

Desai lab develops nano-devices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:

Michael Fischbach and Tejal Desai focus on “micro” solutions to improve health with drugs

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

Tejal Desai’s drug delivery research focus of agreement between UCSF and Zcube

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube s.r.l.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of Contents

Scientists Explain How They Are Making Therapeutics "Intelligent"

UCSF scientists from the Department of Bioengineering and Therapeutic Sciences and UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, spoke on June 23, 2009 about how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.

Giacomini and Benet Honored by International Peers

Kathy M. Giacomini, PhD, chair, department of biopharmaceutical sciences and Leslie Z. Benet, PhD, professor in the same department, were both honored at the Pharmaceutical Sciences World Congress, held May 29 to June 4, 2004 in Kyoto, Japan.

Leslie Z. Benet Named Thomson ISI Highly Cited Researcher

Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure influence in science through time.